Device to treat depression gets EU backingMay 8, 2019
The European Commission has given its nod to BNA-Predict technology for treating people suffering from depression.
BNA-Predict has been developed to predict responsiveness to both antidepressants and neurostimulation treatments and help physicians select the most effective antidepressant treatment and monitor treatment effect directly in the brain for patients suffering from depression.
The use of BNA-Predict increases treatment effectiveness reduces healthcare costs as well as cuts down mortality from the disease, the company said in a statement.
Over 50 million Europeans are suffering from depression, a devastating disease with significant social and financial impact on the community. Depression is the number one cause of disability and accounts for more than 30% of the total cost associated with brain-related diseases.
Selecting the right treatment for depressive patients presents an enormous challenge for doctors and the success rate is less than 50%.